Jul 21, 2021 / 11:00AM GMT
Operator
Ladies and gentlemen, welcome to the Sobi Q2 report. (Operator Instructions) I will now hand over to Guido Oelkers, CEO. Please go ahead with your meeting.
Guido Oelkers - Swedish Orphan Biovitrum AB(publ)-CEO&President
Yes. It's a great pleasure to welcome you to the Q2 webcast today. As you probably have seen, we have some exciting news to share. And very pleased that you have an interest in the company. With this said, let's go right into the session.
Forward-looking statements, please, next slide. Yes. Please just take note of this and as per usual didn't expect you to read it.
I'm joined today by our CFO, Henrik Stenqvist, and our Head of R&D, Ravi Rao. And with this having said, let's go right into the numbers and the data points. So when you look at the -- at our performance during the Q2, we're very happy that we were back to double-digit growth. We had 14% growth, as reported. And we're quite pleased with particularly strong Doptelet, the 42% growth is including the milestone
Q2 2021 Swedish Orphan Biovitrum AB (publ) Earnings Call Transcript
Jul 21, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers